Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Dec;30(3):421–428.

T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.

R J Rand, D M Jenkins, R Bulmer
PMCID: PMC1541147  PMID: 304787

Abstract

Lymphocyte subpopulations in patients with pre-invasive and invasive cervical carcinoma, other gynaecological malignancies and controls were studied. T lymphocytes were recognized by their ability to form spontaneous rosettes with sheep red blood cells (E rosettes). Two surface marker characteristics were used to detect B lymphocytes: the receptors for activated complement responsible for erythrocyte-antibody-complement (EAC) rosette formation, and surface membrane immunoglobulin (SMIg), which is readily stainable by immunofluorescence. There was a significant depression in T cells in association with invasive but not pre-invasive cervical carcinoma. The results for B cells varied according to the method used for their detection. EAC rosette-forming (EAC-RFC) were significantly raised in patients with invasive cancers but not in patients with pre-invasive cancer. SMIg-bearing cells were not significantly altered by the presence of malignant disease. The changes in E-RFC and EAC-RFC numbers were more marked in patients with extensive cancers. Possible functional implications of these findings are discussed.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablin R. J., Baird W. M. Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer. JAMA. 1972 Jan;219(1):87–87. [PubMed] [Google Scholar]
  2. Ashman R., Johnson K., Nahmias A. Letter: Rosette-forming lymphocytes in cervical in-situ carcinoma. Lancet. 1975 Dec 13;2(7946):1212–1212. doi: 10.1016/s0140-6736(75)92703-8. [DOI] [PubMed] [Google Scholar]
  3. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  4. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blomgren H., Glas U., Melén B., Wasserman J. Blood lymphocytes after radiation therapy of mammary carcinoma. Acta Radiol Ther Phys Biol. 1974 Jun;13(3):185–200. doi: 10.3109/02841867409129875. [DOI] [PubMed] [Google Scholar]
  6. Brooks W. H., Roszman T. L., Rogers A. S. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. Cancer. 1976 Apr;37(4):1869–1873. doi: 10.1002/1097-0142(197604)37:4<1869::aid-cncr2820370435>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  7. Bulmer R., Hancock K. W. Depletion of circulating T lymphocytes in pregnancy. Clin Exp Immunol. 1977 May;28(2):302–305. [PMC free article] [PubMed] [Google Scholar]
  8. Catalona W. J., Potvin C., Chretien P. B. T lymphocytes in bladder and prostatic cancer patients. J Urol. 1974 Sep;112(3):378–382. doi: 10.1016/s0022-5347(17)59735-9. [DOI] [PubMed] [Google Scholar]
  9. Dellon A. L., Potvin C., Chretien P. B. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment. Cancer. 1975 Mar;35(3):687–694. doi: 10.1002/1097-0142(197503)35:3<687::aid-cncr2820350322>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Dennert G. Evidence for non-identity of T killer and T helper cells sensitised to allogeneic cell antigens. Nature. 1974 May 24;249(455):358–360. doi: 10.1038/249358a0. [DOI] [PubMed] [Google Scholar]
  11. Feldman M., Cohen I. R., Wekerle H. T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis. Transplant Rev. 1972;12:57–90. doi: 10.1111/j.1600-065x.1972.tb00053.x. [DOI] [PubMed] [Google Scholar]
  12. Fudenberg H. H., Wybran J., Robbins D. Editorial: T-rosette forming cells, cellular immunity and cancer. N Engl J Med. 1975 Feb 27;292(9):475–476. doi: 10.1056/NEJM197502272920910. [DOI] [PubMed] [Google Scholar]
  13. Garrioch D. B., Good R. A., Gatti R. A. Lymphocyte response to P.H.A. in patients with non-lymphoid tumours. Lancet. 1970 Mar 21;1(7647):618–618. doi: 10.1016/s0140-6736(70)91658-2. [DOI] [PubMed] [Google Scholar]
  14. Goh K., Reddy M. M. B and T lymphocytes in man. II. Circulating B and T lymphocytes in cancer patients. J Med. 1976;7(3-4):297–305. [PubMed] [Google Scholar]
  15. Grant R. M., Mackie R., Cochran A. J., Murray E. L., Hoyle D., Ross C. Results of administering B.C.G. to patients with melanoma. Lancet. 1974 Nov 9;2(7889):1096–1100. doi: 10.1016/s0140-6736(74)90867-8. [DOI] [PubMed] [Google Scholar]
  16. Han T., Takita H. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Cancer. 1972 Sep;30(3):616–620. doi: 10.1002/1097-0142(197209)30:3<616::aid-cncr2820300304>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  17. Herberman R. B. Immunologic approaches to the diagnosis of cancer. Cancer. 1976 Jan;37(1 Suppl):549–561. doi: 10.1002/1097-0142(197601)37:1+<549::aid-cncr2820370720>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  18. Holland P. D., Browne O., Thornes R. D. The enhancing influence of proteolysis on E rosette forming lymphocytes (T cells) in vivo and in vitro. Br J Cancer. 1975 Feb;31(2):164–169. doi: 10.1038/bjc.1975.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jenkins V. K., Olson M. H., Ellis H. N., Dillard E. A., Jr In vitro lymphocyte response of patients with uterine cancer as related to clinical stage and radiotherapy. Gynecol Oncol. 1975 Sep;3(3):191–200. doi: 10.1016/s0090-8258(75)80002-3. [DOI] [PubMed] [Google Scholar]
  20. Katz D. H., Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972;15:1–94. doi: 10.1016/s0065-2776(08)60683-5. [DOI] [PubMed] [Google Scholar]
  21. Kerman R. H., Smith R., Stefani S. S., Ezdinili E. Z. Active T-rosette-forming cells in the peripheral blood of cancer patients. Cancer Res. 1976 Sep;36(9 PT1):3274–3278. [PubMed] [Google Scholar]
  22. Klein W. J., Jr Lymphocyte-mediated cytotoxicity in vitro. Effect of enhancing antisera. J Exp Med. 1971 Nov 1;134(5):1238–1252. doi: 10.1084/jem.134.5.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koziner B., Cosimi A. B., Bloch K. J. Distribution of latex-ingesting cells, T cells, and B cells in the peripheral blood of patients with malignant melanoma. J Natl Cancer Inst. 1975 Dec;55(6):1295–1299. doi: 10.1093/jnci/55.6.1295. [DOI] [PubMed] [Google Scholar]
  24. Papamichail M., Brown J. C., Holborow E. J. Immunoglobulins on the surface of human lymphocytes. Lancet. 1971 Oct 16;2(7729):850–852. doi: 10.1016/s0140-6736(71)90224-8. [DOI] [PubMed] [Google Scholar]
  25. Papamichail M., Holborow E. J., Keith H. I., Currey H. L. Subpopulations of human peripheral blood lymphocytes distinguished by combined rosette formation and membrane immunofluorescence. Lancet. 1972 Jul 8;2(7767):64–66. doi: 10.1016/s0140-6736(72)91553-x. [DOI] [PubMed] [Google Scholar]
  26. Porreco R., Penn I., Droegemueller W., Greer B., Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol. 1975 Apr;45(4):359–364. [PubMed] [Google Scholar]
  27. Potvin C., Tarpley J. L., Chretien B. Thymus-derived lymphocytes in patients with solid malignancies. Clin Immunol Immunopathol. 1975 Mar;3(4):476–481. doi: 10.1016/0090-1229(75)90072-0. [DOI] [PubMed] [Google Scholar]
  28. Raben M., Walach N., Galili U., Schlesinger M. The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer. 1976 Mar;37(3):1417–1421. doi: 10.1002/1097-0142(197603)37:3<1417::aid-cncr2820370324>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  29. Rugarli C., Scorza R., Sabbadini M. G. Letter: Unblocking of T lymphocytes. Lancet. 1975 Jun 7;1(7919):1297–1298. doi: 10.1016/s0140-6736(75)92583-0. [DOI] [PubMed] [Google Scholar]
  30. Seitanides B., Georgoulis B. Letter: rosette-forming-lymphocyte counts in cancer of the colon. Lancet. 1975 Feb 22;1(7904):461–461. doi: 10.1016/s0140-6736(75)91539-1. [DOI] [PubMed] [Google Scholar]
  31. Silveira N. P., Mendes N. F., Tolnai M. E. Tissue localization of two populations of human lymphocytes distinguished by membrane receptors. J Immunol. 1972 May;108(5):1456–1460. [PubMed] [Google Scholar]
  32. Taussig M. J. Demonstration of suppressor T cells in a population of 'educated' T cells. Nature. 1974 Mar 15;248(445):236–238. doi: 10.1038/248236a0. [DOI] [PubMed] [Google Scholar]
  33. Wanebo H. J., Jun M. Y., Strong E. W., Oettgen H. T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg. 1975 Oct;130(4):445–451. doi: 10.1016/0002-9610(75)90482-1. [DOI] [PubMed] [Google Scholar]
  34. Weston W. L., Thorne E. G. Letter: Profound T lymphopenia in dermatomyositis with cancer. N Engl J Med. 1974 Jul 25;291(4):208–208. doi: 10.1056/NEJM197407252910417. [DOI] [PubMed] [Google Scholar]
  35. Whitehead R. H., Thatcher J., Teasdale C., Roberts G. P., Hughes L. E. T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro. Lancet. 1976 Feb 14;1(7955):330–333. doi: 10.1016/s0140-6736(76)90085-4. [DOI] [PubMed] [Google Scholar]
  36. Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet. 1971 May 1;1(7705):892–893. doi: 10.1016/s0140-6736(71)92448-2. [DOI] [PubMed] [Google Scholar]
  37. Williams R. C., Jr, Messner R. P. Alterations in T- and B-cells in human disease states. Annu Rev Med. 1975;26:181–192. doi: 10.1146/annurev.me.26.020175.001145. [DOI] [PubMed] [Google Scholar]
  38. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES